Onderneming Sigma Healthcare Ltd Australian S.E.
Aandelen
AU000000SIP6
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- AUD | - |
30/05 | Transcript : Sigma Healthcare Limited - Shareholder/Analyst Call | |
02/05 | Boral verlaat S&P/ASX 200 Index na overnamebod | MT |
Vakgebied
Verkoop per activiteit
AUD in miljoen | 2023 | Gewicht | 2024 | Gewicht | Delta |
---|---|---|---|---|---|
Healthcare
100,0
%
| 3 660 | 100,0 % | 3 322 | 100,0 % | -9,24% |
Verkoop per regio
AUD in miljoen | 2023 | Gewicht | 2024 | Gewicht | Delta |
---|---|---|---|---|---|
Australia
100,0
%
| 3 660 | 100,0 % | 3 322 | 100,0 % | -9,24% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Vikesh Ramsunder
CEO | Chief Executive Officer | 53 | 01-02-22 |
Mark Conway
DFI | Director of Finance/CFO | - | 01/11 |
Martin Hawkins
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-20 |
Gary Woodford
IRC | Investor Relations Contact | - | - |
Kara McGowan
LAW | General Counsel | - | 21-10-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chris Roberts
BRD | Director/Board Member | 70 | 06-10-23 |
Kathryn Spargo
BRD | Director/Board Member | 72 | 09-12-15 |
Michael Sammells
CHM | Chairman | - | 01-02-20 |
Neville Mitchell
BRD | Director/Board Member | 65 | 02-02-23 |
Vikesh Ramsunder
CEO | Chief Executive Officer | 53 | 01-02-22 |
Annette Carey
BRD | Director/Board Member | 63 | 01-04-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 631 866 135 | 1 511 462 039 ( 92,62 %) | 61 294 143 ( 3,756 %) | 92,62 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
SIGMA HEALTHCARE LIMITED 2.10% | 34 243 488 | 2.10% | 28 128 628 $ |
Bedrijfsgegevens
Sigma Healthcare Ltd.
2125 Dandenong Road Level 6
3168, Clayton
+61 3 9215 9215
http://www.sigmahealthcare.com.au/Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+23,03% | 74,04 mld. | |
-1,52% | 24,18 mld. | |
+3,67% | 8,46 mld. | |
+8,55% | 8,34 mld. | |
-23,71% | 7,64 mld. | |
+15,20% | 5,33 mld. | |
+2,68% | 4,12 mld. | |
-6,90% | 3,92 mld. | |
+5,56% | 3,89 mld. |